Canadian researcher develops first animal model to study function of C9ORF72 in ALS

NewsGuard 100/100 Score

ALS Canada-funded research continuing to turn up positive results

Canadian researcher Edor Kabashi of the Université de Montréal has developed the first animal model to study the function of a gene responsible for the highest percentage of ALS, commonly known as Lou Gehrig's disease. Results to date shed light on the cause of the devastating disease.

"Our results indicate that normal levels of a gene called C9ORF72 are crucial for the proper motor function of zebrafish, and loss of its function causes neurodegeneration," explains Dr. Kabashi.

This is vital information, as ALS is caused by the death of motor neurons connecting the brain to the muscles. While the specific causes of ALS have eluded scientists for years, the announcement from Dr. Kabashi represents an important step forward, in hopes of finding new therapies and someday, a cure.

"Canadian researchers are recognized internationally for discoveries that further our understanding of ALS," said Lindee David , CEO, ALS Canada. "It is a promising time for the ALS community. We are proud to support their work and are excited by Dr. Kabashi's findings."

First ever published animal model to study the function of gene C9ORF72

In 2011, two international consortia identified that mutations in C9ORF72 cause a higher percentage of familial and sporadic ALS than any other gene previously discovered. It was determined that the mutation makes up approximately one-third of all familial cases of ALS.

Following the important discovery, Dr. Kabashi and Dr. Pierre Drapeau , also of Université de Montréal, were co-awarded the ALS Canada-funded Bernice Ramsay Discovery Grant to create zebrafish models of reduced and mutated C9ORF72. The purpose was to determine the gene's role in motor function and ability to cause neurodegeneration. Initial results from the research have recently been accepted for publication in the prestigious journal Annals of Neurology.

"To validate whether normal levels and/or function of C9ORF72 is essential for motor neuron health and activity, we developed an animal model to observe disease presentation in zebrafish," said Dr. Kabashi "We observed clear motor dysfunction, swimming defects, and abnormalities at the cellular level."

"Our hope is that these new animal models of ALS will help identify new avenues for therapy. Many more cellular and animal models of C9ORF72 are currently being studied and we look forward to continued exciting discoveries in what promises to be another breakthrough year for ALS research." added David.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how genetic changes in SCN2A gene impact autism and epilepsy